<DOC>
	<DOCNO>NCT01003158</DOCNO>
	<brief_summary>The main purpose study determine AZD8931 safely administer Japanese patient alone combination weekly paclitaxel . The study conduct two part : monotherapy combination part , safe dos study treatment determine .</brief_summary>
	<brief_title>Study Assessing Safety Tolerability AZD8931 Alone Combination With Paclitaxel Japanese Patients .</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Cancer refractory standard therapy , standard therapy exist ( monotherapy part ) Patients suitable Paclitaxel chemotherapy , candidate hormonal anthracycline therapy ( combination part ) Life expectancy 12 week Inadequate kidney , liver , heart , gastric , lung eye function Brain metastasis Hypersensitive paclitaxel ( combination part )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Cancer</keyword>
	<keyword>tumour</keyword>
	<keyword>metastatic</keyword>
	<keyword>breast cancer</keyword>
</DOC>